Skip to main content
Seegnal logo

Seegnal — Investor Relations & Filings

Ticker · SEGN ISIN · CA81573E1060 TSXV Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 102 across all filing types
Latest filing 2026-04-01 Regulatory Filings
Country CA Canada
Listing TSXV SEGN

About Seegnal

https://www.seegnal.com/

Seegnal is a healthcare technology provider specializing in SaaS clinical decision support solutions, marketed as the enterprise Prescription Operating System (Prescription OS). The platform's core function is to mitigate Adverse Drug Effects (ADEs) and reduce patient risk by enabling precision prescribing. Seegnal continuously analyzes prescribing decisions in real-time, leveraging comprehensive clinical context, including patient medications, diagnoses, and lab results. This system delivers measurable clinical ROI and significantly reduces alert fatigue, reportedly lowering alert load by up to 94%. Key modules, such as Seegnal Guard and MetricsGuard, provide real-time, explainable alerts, empowering clinicians while ensuring that all final prescribing decisions remain fully under their control.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a press release announcing Seegnal’s establishment of a new Strategic Commercialization Team and the engagement of an external investor relations advisor. It does not present financial results (so it’s not ER/IR/10-K), nor is it a management or board change (MANG relates to director or senior officer appointments). It does not announce dividends, capital changes, share transactions, or M&A activity. This type of general corporate/regulatory announcement that does not fit a more specific category falls under the fallback “Regulatory Filings” (RNS).
2026-04-01 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate press release announcing the establishment of a new Strategic Commercialization Team and engagement of an investor relations advisor. There is no discussion of financial results, dividends, securities issuance, major shareholdings, M&A activity, legal proceedings, or ESG reporting. It also does not constitute an Annual Report, Interim Report, Earnings Release, or similar detailed report. Nor is it simply announcing publication of another report. Therefore it best fits into the catch-all Regulatory Filings category (RNS) for miscellaneous corporate announcements.
2026-04-01 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a press release issued by Seegnal Inc. announcing the expansion of a deployment of their software platform at a medical center. It follows the standard format of a corporate press release, including 'FOR IMMEDIATE RELEASE', contact information, and a 'Cautionary Note Regarding Forward-Looking Information'. Since it does not fit into specific categories like financial reports, audit reports, or governance filings, and is a general corporate announcement, it is classified as a Regulatory Filing (RNS).
2026-02-03 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a press release issued by Seegnal Inc. announcing the results of a clinical study presented at the CALTCM Summit. It follows the standard format of a corporate press release, including a headline, dateline, company boilerplate, and forward-looking statement disclaimers. Since it does not fit into specific categories like financial reports, proxy statements, or governance filings, and is a general corporate announcement, it is classified as a Regulatory Filing (RNS).
2026-01-27 English
News release - English.pdf
AGM Information Classification · 1% confidence The document is a press release announcing upcoming virtual investor meetings with the CEO of Seegnal Inc. It provides details on the schedule, the purpose of the meetings, and contact information. It does not contain the actual transcript of a call, nor is it a formal financial report or regulatory filing. As it is a general corporate announcement regarding investor relations activities, it falls under the 'Regulatory Filings' (RNS) category as a catch-all for miscellaneous corporate announcements that do not fit into more specific categories like Earnings Releases or Investor Presentations.
2026-01-13 English
Material change report - English.pdf
Board/Management Information Classification · 1% confidence The document is a Canadian Form 51-102F3 Material Change Report announcing the appointment of a new Vice President of Artificial Intelligence. This is an official announcement of a senior management change. Under our taxonomy, announcements of changes in a company’s board or senior management fall under Board/Management Information (MANG).
2026-01-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.